﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Academy of Medical Sciences of I.R. Iran</PublisherName>
      <JournalTitle>Archives of Iranian Medicine</JournalTitle>
      <Issn>1029-2977</Issn>
      <Volume>18</Volume>
      <Issue>4</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2015</Year>
        <Month>04</Month>
        <DAY>01</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>Epithelial-myoepithelial Carcinoma - Review of Clinicopathological and Immunohistochemical Features</ArticleTitle>
    <FirstPage>0</FirstPage>
    <LastPage>0</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Milovan V</FirstName>
        <LastName>Dimitrijevic</LastName>
      </Author>
      <Author>
        <FirstName>Nada R</FirstName>
        <LastName>Tomanovic</LastName>
      </Author>
      <Author>
        <FirstName>Snezana</FirstName>
        <LastName>D. Jesic</LastName>
      </Author>
      <Author>
        <FirstName>Nenad A</FirstName>
        <LastName>Arsovic</LastName>
      </Author>
      <Author>
        <FirstName>Aleksandar</FirstName>
        <LastName>Lj Mircic</LastName>
      </Author>
      <Author>
        <FirstName>Aleksandar M</FirstName>
        <LastName>Krstic</LastName>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">
      </ArticleId>
    </ArticleIdList>
    <History>
    </History>
    <Abstract> INTRODUCTION: Epithelial-myoepithelial carcinoma is a low-grade malignant salivary gland neoplasm with a biphasic cell population that encompasses around 1% of all salivary neoplasms. METHOD: We present different cases of epithelial-myoepithelial carcinoma, with special emphasis on histopathology, differential diagnosis, relevant prognostic factors and follow-up. RESULT: This study included 8 patients who were diagnosed with epithelial-myoepithelial carcinoma and treated surgically including a follow-up period of at least 19 months. CONCLUSION: Clinical and histopathological characteristics of these rare tumors are extremely valuable for accurate diagnosis and further therapy planning.</Abstract>
  </Article>
</ArticleSet>